White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

Not recruiting

3 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Fluticasone Propionate
- Salbutamol Sulfate
+6
Study of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

Not recruiting

2 1
Investigated drugs:
- (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Not recruiting

4 1
Investigated diseases:
Investigated drugs:
- Litifilimab
+5
Study of Pembrolizumab, Lenvatinib, and Chemotherapy for First-Line Treatment in Extensive-Stage Small Cell Lung Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
Investigated drugs:
- Lenvatinib
- Pembrolizumab
Study on the Effects of MYK-224 for Patients with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Not recruiting

2 1 1
Investigated diseases:
- Hypertrophic cardiomyopathy
Investigated drugs:
- Bms-986435
Study of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Cervix carcinoma
Investigated drugs:
Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

Not recruiting

1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Not recruiting

2 1 1
Investigated diseases:
- Renal cell carcinoma
Investigated drugs:
- Mrna-4157
- Pembrolizumab
Study of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy

Not recruiting

2 1 1 1
Investigated diseases:
- HER2 positive breast cancer
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies